Back to Agenda
Public Expectation vs. Regulatory Complexity: Scenarios for Safe Innovation in Medical Technology
Session Chair(s)
Christopher Hodges
Professor , Head of CMS Research Programme on Civil Justice Systems, Oxford University, United Kingdom
In this session challenges and issues of the current European medical device regulatory system (such as inherent complexity, scarcity of available expertise and lack of public understanding) and lessons learnt from the pharmaceutical sector will be identified. The session will follow an interactive format, in which a panel of renowned experts together with the audience will formulate and discuss potential options and solutions.
Speaker(s)
Debater
Gert Bos, PhD, MSc
Chief Scientific Oficer, Executive Director, Partner, Qserve Group B.V., Netherlands
Debater
Robert Geertsma
Senior Scientist/Project Leader, RIVM, Netherlands
Debater
Sabina Hoekstra-van den Bosch, PharmD, MSc, RPh
Global Director Regulatory Strategy, Tüv Süd, Netherlands
Debater
Hugo Hurts
Chair HMA Brexit Task Force; Executive Director, Medicines Evaluation Board (MEB), Netherlands
Debater
Eric Klasen
Vice President, Regulatory Affairs & Quality, Medtronic International Trading Sarl, Switzerland
Debater
John Wilkinson
Director of Devices, MHRA, United Kingdom
Have an account?